SynAct Pharma AB
F:8F8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SynAct Pharma AB
F:8F8
|
SE |
|
DTS Corp
F:DA9
|
JP |
|
S
|
Stellar AfricaGold Inc
XMUN:6YP1
|
CA |
|
Orion Nutraceuticals Inc
F:86OA
|
CA |
|
E
|
Eidesvik Offshore ASA
XMUN:E1V
|
NO |
|
I
|
iMetal Resources Inc
XBER:A7V
|
CA |
|
L
|
Lombard et Medot SA
PAR:MLCAC
|
FR |
|
Discovery Harbour Resources Corp
OTC:DCHRF
|
CA |
|
Harvest Technology Group Ltd
F:HTE
|
AU |
|
G
|
GP Bullhound Acquisition I SE
AEX:BHND
|
LU |
|
Simply Better Brands Corp
OTC:SBBCF
|
CA |
|
IM Cannabis Corp
NASDAQ:IMCC
|
CA |
|
Z
|
ZA Group Inc
OTC:ZAAG
|
US |
|
C
|
Cygnus Oil And Gas Corp
OTC:CYNS
|
US |
|
Pacton Gold Inc
XTSX:PAC
|
CA |
|
S
|
Silicon Laboratories Inc
F:LA5
|
US |
|
Netweek SpA
F:DMM
|
IT |
|
Charlotte's Web Holdings Inc
TSX:CWEB
|
US |
|
Ferroglobe PLC
F:5FG
|
UK |
|
T
|
Tokyo Printing Ink Mfg Co Ltd
TSE:4635
|
JP |
|
THC Biomed Intl Ltd
F:TFHD
|
CA |
Wall St Price Targets
8F8 Price Targets Summary
SynAct Pharma AB
According to Wall Street analysts, the average 1-year price target for 8F8 is 3.224 EUR with a low forecast of 3.192 EUR and a high forecast of 3.319 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8F8's stock price target?
Price Target
3.224
EUR
According to Wall Street analysts, the average 1-year price target for 8F8 is 3.224 EUR with a low forecast of 3.192 EUR and a high forecast of 3.319 EUR.